{{Rsnum
|rsid=13224682
|Gene=PRKAR2B
|Chromosome=7
|position=107122773
|Orientation=plus
|GMAF=0.03306
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PRKAR2B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 85.0 | 12.4 | 2.7
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 94.0 | 6.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 91.4 | 6.9 | 1.7
| MKK | 0.0 | 0.0 | 0.0
| TSI | 81.4 | 18.6 | 0.0
| HapMapRevision=28
}}{{PMID|20195266|OA=1
}} gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 6 x 10^-8 for triglycerides as a result of [[clozapine]] use

{{PMID Auto
|PMID=21162693
|Title=Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}